Morau, M.V.; Seguin, C.S.; Perroud Junior, M.W.; Dagli-Hernandez, C.; Pincinato, E.d.C.; Moriel, P.
Gefitinib-Induced Severe Dermatological Adverse Reactions: A Case Report and Pharmacogenetic Profile. Pharmaceuticals 2024, 17, 1040.
https://doi.org/10.3390/ph17081040
AMA Style
Morau MV, Seguin CS, Perroud Junior MW, Dagli-Hernandez C, Pincinato EdC, Moriel P.
Gefitinib-Induced Severe Dermatological Adverse Reactions: A Case Report and Pharmacogenetic Profile. Pharmaceuticals. 2024; 17(8):1040.
https://doi.org/10.3390/ph17081040
Chicago/Turabian Style
Morau, Mariana Vieira, Cecilia Souto Seguin, Mauricio Wesley Perroud Junior, Carolina Dagli-Hernandez, Eder de Carvalho Pincinato, and Patricia Moriel.
2024. "Gefitinib-Induced Severe Dermatological Adverse Reactions: A Case Report and Pharmacogenetic Profile" Pharmaceuticals 17, no. 8: 1040.
https://doi.org/10.3390/ph17081040
APA Style
Morau, M. V., Seguin, C. S., Perroud Junior, M. W., Dagli-Hernandez, C., Pincinato, E. d. C., & Moriel, P.
(2024). Gefitinib-Induced Severe Dermatological Adverse Reactions: A Case Report and Pharmacogenetic Profile. Pharmaceuticals, 17(8), 1040.
https://doi.org/10.3390/ph17081040
